Blocking follicular T-helper cell driven B-cell stimulation by the IL-21-receptor antagonist is a novel therapeutic option in kidney-transplant patients

2014 ◽  
Vol 31 (4) ◽  
pp. 237
Author(s):  
Gretchen de Graav ◽  
Marjolein Dieterich ◽  
Dennis Hesselink ◽  
Karin Boer ◽  
Marian Clahsen ◽  
...  
2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Sharon Bajda ◽  
Arturo Blazquez-Navarro ◽  
Björn Samans ◽  
Patrizia Wehler ◽  
Sviatlana Kaliszczyk ◽  
...  

Abstract Epstein-Barr virus (EBV) reactivation can lead to serious complications in kidney transplant patients, including post-transplant lymphoproliferative disorder (PTLD). Here, we have assessed the impact of EBV on B cell homeostasis at cellular and humoral level. In a multicenter study monitoring 540 kidney transplant patients during the first post-transplant year, EBV reactivation was detected in 109 patients. Thirteen soluble factors and B cell counts were analyzed in an EBV+ sub-cohort (N = 54) before, at peak and after EBV clearance and compared to a control group (N = 50). The B cell activating factor (BAFF) was significantly elevated among EBV+ patients. No additional soluble factors were associated with EBV. Importantly, in vitro experiments confirmed the proliferative effect of BAFF on EBV-infected B cells, simultaneously promoting EBV production. In contrast, elevated levels of BAFF in EBV+ patients did not lead to B cell expansion in vivo. Moreover, diminished positive inter-correlations of soluble factors and alterations of the bi-directional interplay between B cell and soluble factors were observed in EBV+ patients at peak and after clearance. Our data suggest that such alterations may counteract the proliferative effect of BAFF, preventing B cell expansion. The role of these alterations in lymphoma development should be analyzed in future studies.


2015 ◽  
Vol 180 (2) ◽  
pp. 329-340 ◽  
Author(s):  
G. N. de Graav ◽  
M. Dieterich ◽  
D. A. Hesselink ◽  
K. Boer ◽  
M. C. Clahsen-van Groningen ◽  
...  

2013 ◽  
Vol 14 (1) ◽  
pp. 144-155 ◽  
Author(s):  
M. Chesneau ◽  
A. Pallier ◽  
F. Braza ◽  
G. Lacombe ◽  
S. Le Gallou ◽  
...  

2021 ◽  
Vol 18 (1) ◽  
Author(s):  
Lei Wang ◽  
Christien Rondaan ◽  
Anoek A. E. de Joode ◽  
Elisabeth Raveling-Eelsing ◽  
Nicolaas A. Bos ◽  
...  

Abstract Background The incidence of kidney transplantation performed in elderly patients has increased steadily recently. Higher risk of infection and mortality, but lower rate of rejection, are reported in older kidney transplant patients. This study aims to analyze the effect of transplantation on aging of T and B cells in kidney transplant patients, with the emphasis on age and Cytomegalovirus (CMV) latency. Results We included 36 patients before and after (median 2.7 years) kidney transplantation and 27 age- and sex-matched healthy controls (HC). T and B cell subsets were measured by flow cytometry, with a focus on aged T cells (CD28-), and age associated B cells (ABCs, CD19 + CD21-CD11c+). Three years after transplantation a significant increase of total T cells among the lymphocytes was found compared to pre-transplantation and HC. Among the T cells CD4+ cells were decreased, especially naïve CD4+ cells and regulatory T cells. Total CD8+ cell proportions were increased, and proportions of naïve CD8+ cells were significantly decreased after transplantation, while CD8+ effector memory T cells re-expressing CD45RA were increased. CD28− T cells were significantly higher compared to HC after transplantation, especially in CMV seropositive patients. B cells were significantly decreased, while among B cells memory B cells and especially ABCs were increased after transplantation. Conclusions After transplantation T and B cell subsets change towards more terminally differentiated memory cells compared to age-matched HC. Proportions of aged T cells and ABCs were associated with CMV serostatus.


Sign in / Sign up

Export Citation Format

Share Document